AstraZeneca's COVID Vaccine Still Has Market Potential Despite an Expected Global ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'AstraZeneca's COVID vaccine still has market potential despite an expected global oversupply of shots and delays in the vaccine's approval in the U.S., its chief executive Pascal Soriot said ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)